<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="110955">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01913665</url>
  </required_header>
  <id_info>
    <org_study_id>not defined yet</org_study_id>
    <nct_id>NCT01913665</nct_id>
  </id_info>
  <brief_title>The Effect of Bifidobacterium Lactis and Inulin on Functional Constipation</brief_title>
  <official_title>The Effect of Bifidobacterium Lactis and Inulin on Functional Constipation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eskisehir Osmangazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eskisehir Osmangazi University</source>
  <oversight_info>
    <authority>Turkey: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to asses the effect of Bifidobacterium lactis and Inulin on
      functional constipation in children
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>to compare defecation frequency between baseline and 4 th week of treatment</measure>
    <time_frame>baseline and 4th week of intervention</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Functional Constipation</condition>
  <arm_group>
    <arm_group_label>B.Lactis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>children with functional constipation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inulin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>children with functional constipation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B.Lactis+ınulin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>children with functional constipation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>plasebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>children with functional constipation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>B.lactis</intervention_name>
    <arm_group_label>B.Lactis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Inulin</intervention_name>
    <arm_group_label>Inulin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>B.Lactis +Inulin</intervention_name>
    <arm_group_label>B.Lactis+ınulin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>plasebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  children with functional constipation over 3 years age

          -  below 18 years of age

        Exclusion Criteria:

          -  Chronic gastrointestinal disease,

          -  hirschsprung disease,

          -  celiac disease,

          -  hypothyroids,

          -  neurological deficit,

          -  constipation treatment receiving children will be excluded
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Makbule Eren, Associate professor</last_name>
    <phone>00902222392979</phone>
    <phone_ext>2763,2750,2716</phone_ext>
    <email>makbule99@yahoo.com</email>
  </overall_contact>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 5, 2013</lastchanged_date>
  <firstreceived_date>July 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eskisehir Osmangazi University</investigator_affiliation>
    <investigator_full_name>Makbule Eren</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
